UTI - Gold Exchange Traded Fund vs Axis Gold ETF
UTI - Gold Exchange Traded Fund (Direct) and Axis Gold ETF head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Gold ETF schemes — see the best gold etfs for the full ranking.
Head to head
NAVs as of 09 Oct 2026
Growth of ₹100 (rebased over the selected window)
Common period 16 Nov 2010 – 09 Oct 2026, limited by Axis Gold ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Gold history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | UTI - Gold Exchange Traded Fund | Axis Gold ETF |
|---|---|---|
| 16 Nov 2010 | ₹100.00 | ₹100.00 |
| 14 Mar 2012 | ₹133.42 | ₹132.83 |
| 11 Jul 2013 | ₹128.65 | ₹127.90 |
| 07 Nov 2014 | ₹120.09 | ₹119.34 |
| 04 Mar 2016 | ₹142.85 | ₹141.92 |
| 01 Jul 2017 | ₹133.49 | ₹128.61 |
| 28 Oct 2018 | ₹146.78 | ₹141.11 |
| 24 Feb 2020 | ₹196.56 | ₹189.80 |
| 22 Jun 2021 | ₹209.67 | ₹203.80 |
| 19 Oct 2022 | ₹218.66 | ₹214.29 |
| 14 Feb 2024 | ₹266.53 | ₹260.12 |
| 12 Jun 2025 | ₹420.31 | ₹405.34 |
| 09 Oct 2026 | ₹635.15 | ₹613.97 |
| Metric | UTI · Direct NAV ₹124.64 Moderately High risk ★★★★☆ | Axis NAV ₹123.36 Moderately High risk ★★☆☆☆ |
|---|---|---|
| +21.80%Best in row | +20.66% | |
| +36.72%Best in row | +36.23% | |
| +25.04%Best in row | +24.85% | |
| +16.28%Best in row | +15.98% | |
| +14.12% | +12.09% | |
| +29.84%Best in row | +29.53% | |
| +12.47%Best in row | +9.59% | |
| +10.50%Best in row | +8.96% | |
| +8.94%Best in row | +8.76% | |
| Risk | ||
| 19.93% | 19.34%Best in row | |
| 1.52 | 1.54 | |
| 2.16 | 2.19 | |
| -29.80% | -29.57% | |
| -1.42% | -1.15%Best in row | |
| 1.09 | 1.06 | |
| 102.8%Best in row | 100.3% | |
| 104.7% | 98.6%Best in row | |
| — | 0.52% | |
| ₹3,414Cr | ₹5,471Cr | |
| None | — | |
| Ayush Jain | Aditya Pagaria | |
| 13 Apr 2007 | 16 Nov 2010 | |
| 1.2% | 2.0% | |
7 rows carry the same value for every fund — show
- Benchmark
- Gold
- Lock-in
- —
- Min SIP
- —
- Min lumpsum
- —
- Portfolio turnover
- —
- Holdings
- —
- Top 10 weight
- —
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — UTI - Gold Exchange Traded Fund or Axis Gold ETF?
Over the last 3 years, UTI - Gold Exchange Traded Fund returned +36.72% CAGR against Axis Gold ETF's +36.23%, computed from AMFI NAV history. Over 5 years: UTI - Gold Exchange Traded Fund +25.04% vs Axis Gold ETF +24.85% CAGR. Past returns don't guarantee future performance.
Which fund is riskier — UTI - Gold Exchange Traded Fund or Axis Gold ETF?
UTI - Gold Exchange Traded Fund has shown higher volatility (+19.93% annualized vs Axis Gold ETF's +19.34%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: UTI - Gold Exchange Traded Fund -21.22% vs Axis Gold ETF -22.25%.
Which fund manages more money — UTI - Gold Exchange Traded Fund or Axis Gold ETF?
Axis Gold ETF is the larger fund: UTI - Gold Exchange Traded Fund manages ₹3,414Cr against Axis Gold ETF's ₹5,471Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are UTI - Gold Exchange Traded Fund and Axis Gold ETF in the same category?
Yes — both are Gold ETF schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.